“…HCuS has attracted significant attention from researchers in biomedical therapeutics owing to its excellent photothermal transformation capacity, easiness of synthesis, and high biocompatibility. , Above all, the high drug-loading capacity of HCuS enables it to be loaded with certain drugs or other small molecules to achieve synergy between PTT and other therapies, especially in combination with PDT. , IR780, a near-infrared lipophilic fluorescent dye with intensive light assimilation and emission, has been widely used for tumor therapy and imaging. − One of the attractive aspects of IR780 is that it can be used as PTT and PDT by adjusting the wavelength of the excitation light. As highlighted, numerous reports studied nanostructures based on IR780 with robust 1 O 2 generation ability (type Il photosensitization theory) under irradiation. , Despite its great potential for application, IR780 still suffers from poor solubility in the organism, rapid clearance, and low tumor uptake. − Delivery of IR780 via nanodelivery systems such as mesoporous silica has solved these problems to some extent, , but the abnormal leakage in the circulation and the hypoxic tumor microenvironment are still not well addressed.…”